These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 23208830
41. Emergence and spread of vancomycin resistance among enterococci in Europe. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N. Euro Surveill; 2008 Nov 20; 13(47):. PubMed ID: 19021959 [Abstract] [Full Text] [Related]
42. [Enterococci resistant to glycopeptides]. Cattoir V, Leclercq R. Med Sci (Paris); 2010 Nov 20; 26(11):936-42. PubMed ID: 21106175 [Abstract] [Full Text] [Related]
43. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections. Wagenlehner FM, Lehn N, Witte W, Naber KG. Chemotherapy; 2005 May 20; 51(2-3):64-9. PubMed ID: 15870498 [Abstract] [Full Text] [Related]
44. Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci. Contreras GA, DiazGranados CA, Cortes L, Reyes J, Vanegas S, Panesso D, Rincón S, Díaz L, Prada G, Murray BE, Arias CA. J Hosp Infect; 2008 Dec 20; 70(4):346-52. PubMed ID: 18799242 [Abstract] [Full Text] [Related]
45. Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil. Neves FP, Ribeiro RL, Duarte RS, Teixeira LM, Merquior VL. Int J Antimicrob Agents; 2009 Mar 20; 33(3):211-5. PubMed ID: 19010645 [Abstract] [Full Text] [Related]
46. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203. Johnson PD, Ballard SA, Grabsch EA, Stinear TP, Seemann T, Young HL, Grayson ML, Howden BP. J Infect Dis; 2010 Oct 15; 202(8):1278-86. PubMed ID: 20812846 [Abstract] [Full Text] [Related]
47. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Salgado CD. Am J Infect Control; 2008 Dec 15; 36(10):S175.e5-8. PubMed ID: 19084155 [Abstract] [Full Text] [Related]
49. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). Treitman AN, Yarnold PR, Warren J, Noskin GA. J Clin Microbiol; 2005 Jan 15; 43(1):462-3. PubMed ID: 15635016 [Abstract] [Full Text] [Related]
50. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Willems RJ, Bonten MJ. Curr Opin Infect Dis; 2007 Aug 15; 20(4):384-90. PubMed ID: 17609597 [Abstract] [Full Text] [Related]
51. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Nordmann P, Naas T, Fortineau N, Poirel L. Curr Opin Microbiol; 2007 Oct 15; 10(5):436-40. PubMed ID: 17765004 [Abstract] [Full Text] [Related]
52. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)]. Cantón R, Ruiz-Garbajosa P. Enferm Infecc Microbiol Clin; 2013 Oct 15; 31(8):543-51. PubMed ID: 24041416 [Abstract] [Full Text] [Related]
53. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005. Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, Ormiston D, Conly J, Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol; 2008 Mar 15; 29(3):271-4. PubMed ID: 18241031 [Abstract] [Full Text] [Related]
54. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Hsueh PR, Teng LJ, Pan HJ, Chen YC, Wang LH, Chang SC, Ho SW, Luh KT. Infect Control Hosp Epidemiol; 1999 Dec 15; 20(12):828-33. PubMed ID: 10614607 [Abstract] [Full Text] [Related]
55. Vancomycin-resistant enterococci: 15 years and counting. Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, Johnson CN, Funkhouser E, Chavers LP, Stamm AM, Waites KB. J Hosp Infect; 2003 Mar 15; 53(3):159-71. PubMed ID: 12623315 [Abstract] [Full Text] [Related]
56. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies. Hoshuyama T, Moriguchi H, Muratani T, Matsumoto T. J Infect Chemother; 2008 Oct 15; 14(5):354-60. PubMed ID: 18936888 [Abstract] [Full Text] [Related]
57. Impact of the reduction of environmental and equipment contamination on vancomycin-resistant enterococcus rates. Perugini MR, Nomi SM, Lopes GK, Belei RA, van der Heijden IM, Mostachio AK, Grion C, Couto EB, Costa SF. Infection; 2011 Dec 15; 39(6):587-93. PubMed ID: 21847554 [Abstract] [Full Text] [Related]
58. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ. Emerg Infect Dis; 2005 Jun 15; 11(6):821-8. PubMed ID: 15963275 [Abstract] [Full Text] [Related]
59. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Zirakzadeh A, Patel R. Mayo Clin Proc; 2006 Apr 15; 81(4):529-36. PubMed ID: 16610573 [Abstract] [Full Text] [Related]
60. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Simonsen GS, Andersen BM, Digranes A, Harthug S, Jacobsen T, Lingaas E, Natås OB, Olsvik O, Ringertz SH, Skulberg A, Syversen G, Sundsfjord A. Scand J Infect Dis; 1998 Apr 15; 30(5):465-8. PubMed ID: 10066045 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]